Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
Polyamines are highly regulated essential cations that are elevated in rapidly proliferating tissues, including diverse cancers. Expression analyses in neuroblastomas suggest that upregulation of polyamine pro-synthetic enzymes and downregulation of catabolic enzymes is associated with poor prognosi...
Main Authors: | Laura Dawn Gamble, Michael D Hogarty, Xuenyuan eLiu, David S Ziegler, Glenn M Marshall, Murray D Norris, Michelle eHaber |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00162/full |
Similar Items
-
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
by: Laura D. Gamble, et al.
Published: (2021-04-01) -
Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels
by: Binli Mao, et al.
Published: (2020-04-01) -
MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines
by: Ingo Lange, et al.
Published: (2014-01-01) -
Polyamines directly promote antizyme-mediated degradation of ornithine decarboxylase by the proteasome
by: R. Roshini Beenukumar, et al.
Published: (2015-05-01) -
Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases
by: Nicole LoGiudice, et al.
Published: (2018-02-01)